M, B., 		G, B., 		P, V., 		P, D., 		M, I., & 		B, F.
(2024).
 Dose Selection for Clinical Development in the Treatment of Hypertension: The Aprocitentan Case and Lessons from the Past.
<em>Medical Research Archives, 12</em>(1).
doi:10.18103/mra.v12i1.4962